 Crinetics Pharmaceuticals Inc NASDAQ:CRNX major shareholder Vivo Capital Viii, Llc sold 6,115 shares of the companys stock in a transaction dated Tuesday, April 7th. The stock was sold at an average price of 14.20, for a total transaction of 86,833.00. The sale was disclosed in a document filed with the SEC, which is available at ... 